Skip to content
10-K

Annual Report

ACRO BIOMEDICAL CO., LTD. ACBM

0001640334-25-001300

← back to feed
Filed
Jul 24, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Jul 24, 2025 60.04M sh
Total Liabilities FY 2024 · Dec 31, 2024 $326.95K
Total Liabilities FY 2024 · Dec 31, 2023 $315.47K
Rd Expense FY 2024 · Dec 31, 2024 $0
Rd Expense FY 2024 · Dec 31, 2023 $4.79M
Shares Diluted FY 2024 · Dec 31, 2023 60.04M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$15.45K
Current Liabilities FY 2024 · Dec 31, 2023 $288.58K
Current Assets FY 2024 · Dec 31, 2023 $1.63K
Total Assets FY 2024 · Dec 31, 2023 $58.46K
Eps Diluted FY 2024 · Dec 31, 2023 −$0.15
Sga Expense FY 2024 · Dec 31, 2023 $3.52M
Net Income FY 2024 · Dec 31, 2023 −$8.81M
Operating Income FY 2024 · Dec 31, 2023 −$8.8M
Revenue FY 2024 · Dec 31, 2023 $0
Stockholders Equity FY 2024 · Dec 31, 2022 $486.37K